NEXT

New Jersey Law Journal

Lawsuits Are Flying Over Generic-Drug Disputes: Surge in Patent Litigation

Five of the suits were filed by Esperion Therapeutics, which seeks to stop competitors from selling generic versions of the company's cholesterol drug Nexletol.
4 minute read

Delaware Law Weekly

Pfizer Files Flurry of Lawsuits Over Migraine Medication Patent

Pfizer recently filed seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication, Nurtec, which is used to prevent and treat migraines.
2 minute read

New York Law Journal

Split Panel Restores NY Opioid Law, but Orders State to Refund Millions to Big Pharma

While the Opioid Stewardship Act was upheld, payments made before the law became effective had to be returned.
4 minute read

The Recorder

After Sanctions Row, DLA Piper Leads One Suit Against Bayer's Mirena IUD to Dismissal, as Identical Suit Is Filed

"Bayer is pleased with the plaintiff's decision to voluntarily dismiss these meritless claims against the Company in Sidhu and believes that the replicated claims raised in the Copeland filing are equally baseless," the company said in a statement. "The Company continues to stand behind the safety of the product that is supported by extensive scientific evidence."
5 minute read

Connecticut Law Tribune

Antitrust Class Actions Emerging Against Big Pharma for Alleged Misuse of Patents

"Teva stifled would-be generic competitors to QVAR because the drug laws do not allow for generic substitution of a given drug-device combination unless the generic is approved for that specific drug-device combination," the complaint alleged.
3 minute read

Law.com

'Restoring Dignity to Henrietta Lacks': Unjust Enrichment Claim Regarding 'HeLa Cells' May Proceed Against Pharma Company

"Now, Henrietta Lacks' grandson, Ron Lacks, says Ultragenyx unjustly reaps some of the benefits of the wrongs against his grandmother," District Judge Deborah L. Boardman said. "Ultragenyx says it has done nothing wrong, and Lacks has no viable claim against it. Today, the court reaches one modest conclusion about this dispute: If what Lacks alleges is true, it is plausible that Ultragenyx is liable to Lacks for unjust enrichment."
5 minute read

Corporate Counsel

Surge in Social Media Drug Promotion Driving Calls for More Oversight

"I think the industry would like more clarity from the FDA on what exactly its position is on its authority over social media," said Mahnu Davar, a partner at Arnold & Porter Kaye Scholer.
7 minute read

New Jersey Law Journal

Sanctions Ordered After CEO Skips Deposition in MDL

ZHP sought to invoke the Apex Doctrine, which seeks to limit depositions of individuals at the "apex" of a corporation based on the premise that lower-level employees are likely to have firsthand knowledge of the material facts, and that deposing the top executives of a corporation is likely to impose a significant burden.
5 minute read

The Legal Intelligencer

Judge Expands Ozempic Plaintiffs' Leadership Team, Names 4 Co-Lead Counsel

In a joint statement, the newly appointed leads said they "are honored to have been appointed by Judge Pratter to lead one of the most significant and consequential pharmaceutical injury cases of our time against the manufacturers of diabetes and weight loss drugs such as Ozempic and Wegovy."
3 minute read

The Legal Intelligencer

Group of Fired Scientists Win $26.6M Bucks County Verdict on Counterclaims Against Ex-Employer

The plaintiff alleged in its $849 million suit that its former employees stole trade secrets and set up competing drug companies.
3 minute read

Resources

  • Yearly Roundup: Strategic Insights for Law Firm Decision Making

    Brought to you by CARET Legal

    Download Now

  • Lex Machina Contracts: Commercial Litigation Report 2024

    Brought to you by LexisNexis®

    Download Now

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now